PVM/MA共聚物 T7307

Product Introduction
Bioactivity


英文名: Vorasidenib

描述: Vorasidenib (PVM/MA) 是口服具有活力的、脑渗透的突变体异柠檬酸脱氢酶 1 和 2 双重抑制剂。

体内活性: Vorsidenib reduces tumor growth in a TS603-IDH1R132H mouse xenograft model when administered at a dose of 50 mg/kg.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 125 mg/mL (301.39 mM)


关键字: inhibit | AG 881 | Vorasidenib | Inhibitor | Isocitrate Dehydrogenase (IDH) | AG881

相关产品: Alternaphenol B2 | Olutasidenib | AGI-5198 | DS-1001b | Enasidenib | BAY-1436032 | AGI-6780 | Mutant IDH1-IN-2 | Mutant IDH1-IN-1 | Mutant IDH1 inhibitor

相关库: Drug Repurposing Compound Library | Anti-Cancer Metabolism Compound Library | Glutamine Metabolism Compound Library | Anti-Cancer Drug Library | CNS-Penetrant Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | Metabolism Compound Library | Bioactive Compound Library

PVM/MA共聚物 T7307信息由TargetMol中国为您提供，如您想了解更多关于PVM/MA共聚物 T7307报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途